Morgan Lewis

Related Publications

02/09/12 FDA Issues Three Draft Guidances for Biosimilars
Initial guidance provides insights on regulatory pathway for biosimilars, but does not address many critical issues.
January 2012 The Consumer Financial Protection Bureau: What It Is and What to Expect
12/05/11 Comparative Effectiveness Research: Impact on Pharmaceutical Pricing and Marketing, presented at the QI Productions Conference on Integrating Comparative Effectiveness Research, Philadelphia
View all publications

Related News

08/12/11 Q&A With Morgan Lewis' Steve Mahinka
Stephen Paul Mahinka is interviewed.
07/15/11 Morgan Lewis Serves as Co-Counsel to BHP Billiton on $12.1 Billion Acquisition of Petrohawk
Morgan Lewis served as co-counsel to BHP Billiton on a definitive agreement for BHP Billiton to acquire Petrohawk for $38.75 per share, representing a total equity value of approximately $12.1 billion and a total enterprise value of approximately $15.1 billion.
07/13/11 Morgan Lewis Team Advises Kinetic Concepts on Company’s $6.3 Billion Acquisition by Apax
Morgan Lewis advised Kinetic Concepts, Inc. (KCI), on a definitive merger agreement under which a consortium comprised of private equity funds will acquire KCI in a $6.3 billion transaction.
View all news
Photo of Stephen Paul Mahinka

Practice Areas

Bar Admissions

  • District of Columbia
View Printable List

Stephen Paul Mahinka

V-Card
Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5205
Fax: 202.739.3001

61 Publications Found
next page show all
page 1 of 3
Date Title Publication
02/09/1202/09/12 FDA Issues Three Draft Guidances for Biosimilars

pdf View LawFlash
Life Sciences and Healthcare LawFlash
01/19/12January 2012 The Consumer Financial Protection Bureau: What It Is and What to Expect

pdf View White Paper
White Paper
12/05/1112/05/11 Comparative Effectiveness Research: Impact on Pharmaceutical Pricing and Marketing, presented at the QI Productions Conference on Integrating Comparative Effectiveness Research, Philadelphia

pdf View Presentation
Speech
12/01/1112/01/11 FTC/DOJ Final Policy Statement on Accountable Care Organizations: Important Antitrust Issues Remain Unanswered, BNA's Health Law Reporter

pdf View Article
Article
10/31/1110/31/11 FTC/DOJ Final Policy on Accountable Care Organizations: Important Antitrust Issues Remain Uncertain for Healthcare Collaborations

pdf View LawFlash
Life Sciences and Healthcare LawFlash
10/18/1110/18/11 The CFIUS Review Process: Trends and Challenges, presented to the Delegation of the State-owned Assets Supervision and Administration Commission (SASAC), People’s Republic of China

pdf View Presentation
Speech
09/23/1109/23/11 The Biosimilars Competition and Innovation Act: Overview and Life Cycle Planning for Biosimilars, presented at American Conference Institute’s FDA Boot Camp, Boston

pdf View Presentation
Speech
06/06/1106/06/11 New Government Healthcare Policies - Impact on Growth and Investment in the Biopharma Industry, presented at the US – Japan Health Sciences Dialogue 11th Annual Meeting, Philadelphia

pdf View Presentation
Speech
05/23/1105/23/11 FDA Requests Comments on the Development of a User Fee Program for Biosimilar and Interchangeable Biological Products

pdf View LawFlash
Life Sciences and Healthcare LawFlash
03/03/1103/03/11 China's New National Security Review Process for Foreign Investments: U.S. CFIUS Review Moves East

pdf View LawFlash
International Alert
01/21/1101/21/11 Prevent Legal Risk, Be Successful in the U.S. Market, China Enterprise News (View Article)


 Article
01/07/1101/07/11 FDA Food Safety Modernization Act Summary

pdf View Article
FDA and Healthcare LawFlash
12/23/1012/23/10 FDA Food Safety Modernization Act Greatly Expands FDA Enforcement Powers

pdf View LawFlash
FDA and Healthcare LawFlash
12/14/1012/14/10 The Antitrust Merger Review Process

pdf View Presentation
Speech
12/13/1012/13/10 The CFIUS Review Process

pdf View Presentation
Speech
10/28/1010/28/10 Preparing for a Biotechnology M&A – Corporate and Regulatory Insight to Keep Ahead of the Competition

pdf View Presentation
Speech
10/14/1010/14/10 Implications of DOJ / FTC Revised Merger Guidelines

pdf View Presentation
Webinar
10/07/1010/07/10 FTC Releases Proposed "Green Guides" Revisions

pdf View LawFlash
Cross-Practice Alert
07/20/1007/20/10 Potential Effects of Healthcare Reform Law on the Medical Device Industry and its Customers

pdf View Presentation
Speech
07/12/1007/12/10 Proposed Merger Reform's Effects On FERC Analysis, Law360

pdf View Article
Article
05/11/1005/11/10 Life Sciences Mergers and Acquisitions: How Healthcare Reform Will Change Your Partnership Strategy, presented at a Elsevier Business Intelligence Webinar

pdf View Presentation
Speech
04/22/1004/22/10 How Regulatory Structures are Taking into Account Scientific Developments in Assessing Approved Food Contact Products, presented at the 2010 Food and Drug Law Institute Annual Conference, Washington, D.C.

pdf View Presentation
Speech
04/19/1004/19/10 Healthcare Reform Law: Comparative Effectiveness Provisions Concerning Healthcare Products and Services

pdf View LawFlash
Washington Government Relations and Public Policy LawFlash
12/01/09November/December 2009 21st Century Toxicology and its Implications for FDA Regulation of Food-Contact Substances, FDLI Update

pdf View Article
Article
10/01/0910/01/09 New Trends Affecting Pharmaceutical and Medical Device Life Cycle Risk Management, presented at the Fourth National FDA Regulatory Symposium, Washington, D.C.

pdf View Presentation
Speech
next page show all
page 1 of 3